Spotlight on Humacyte: Analyzing the Surge in Options Activity
Spotlight on Humacyte: Analyzing the Surge in Options Activity
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Humacyte's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Humacyte's significant trades, within a strike price range of $4.0 to $7.5, over the past month.Financial giants have made a conspicuous bearish move on Humacyte. Our analysis of options history for Humacyte (NASDAQ:HUMA) revealed 9 unusual trades.
金融巨頭對Humacyte採取了明顯的看跌舉動。我們對Humacyte（納斯達克股票代碼：HUMA）期權歷史的分析顯示了9筆不尋常的交易。
Delving into the details, we found 11% of traders were bullish, while 77% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $370,504, and 4 were calls, valued at $132,840.
深入研究細節，我們發現11％的交易者看漲，而77％的交易者表現出看跌趨勢。在我們發現的所有交易中，有5筆是看跌期權，價值370,504美元，4筆是看漲期權，價值132,840美元。
Expected Price Movements
預期的價格走勢
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $4.0 to $7.5 for Humacyte over the recent three months.
根據交易活動，看來重要投資者的目標是在最近三個月中將Humacyte的價格範圍從4.0美元擴大到7.5美元。
Volume & Open Interest Development
成交量和未平倉合約發展
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Humacyte's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Humacyte's significant trades, within a strike price range of $4.0 to $7.5, over the past month.
檢查交易量和未平倉合約爲股票研究提供了至關重要的見解。這些信息是衡量Humacyte期權在特定行使價下的流動性和利息水平的關鍵。下面，我們簡要介紹了過去一個月Humacyte重大交易的看漲期權和未平倉合約的趨勢，行使價區間爲4.0美元至7.5美元。
Humacyte Call and Put Volume: 30-Day Overview
Humacyte 看漲和看跌交易量：30 天概述
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HUMA | PUT | SWEEP | BEARISH | 01/17/25 | $1.35 | $1.3 | $1.35 | $5.50 | $114.5K | 21 | 384 |
| HUMA | PUT | SWEEP | BEARISH | 03/21/25 | $1.45 | $1.4 | $1.45 | $5.00 | $100.0K | 4.4K | 63 |
| HUMA | PUT | SWEEP | BEARISH | 02/21/25 | $1.45 | $1.25 | $1.45 | $5.00 | $64.8K | 10 | 512 |
| HUMA | PUT | SWEEP | BULLISH | 01/17/25 | $0.7 | $0.65 | $0.65 | $4.50 | $57.9K | 141 | 908 |
| HUMA | CALL | TRADE | BEARISH | 12/20/24 | $2.25 | $2.0 | $2.0 | $4.00 | $40.0K | 1.0K | 208 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 人類 | 放 | 掃 | 粗魯的 | 01/17/25 | 1.35 美元 | 1.3 美元 | 1.35 美元 | 5.50 美元 | 114.5 萬美元 | 21 | 384 |
| 人類 | 放 | 掃 | 粗魯的 | 03/21/25 | 1.45 美元 | 1.4 美元 | 1.45 美元 | 5.00 美元 | 100.0K 美元 | 4.4K | 63 |
| 人類 | 放 | 掃 | 粗魯的 | 02/21/25 | 1.45 美元 | 1.25 美元 | 1.45 美元 | 5.00 美元 | 64.8 萬美元 | 10 | 512 |
| 人類 | 放 | 掃 | 看漲 | 01/17/25 | 0.7 美元 | 0.65 美元 | 0.65 美元 | 4.50 美元 | 57.9 萬美元 | 141 | 908 |
| 人類 | 打電話 | 貿易 | 粗魯的 | 12/20/24 | 2.25 美元 | 2.0 美元 | 2.0 美元 | 4.00 美元 | 40.0 萬美元 | 1.0K | 208 |
About Humacyte
關於 Humacyte
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
Humacyte Inc正在開發一個顛覆性的生物技術平台，以提供可普遍植入的生物工程人體組織和器官，旨在改善患者的生活並改變醫學實踐。它開發和製造無細胞組織，用於治療各種疾病、損傷和慢性病。
After a thorough review of the options trading surrounding Humacyte, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在對圍繞Humacyte的期權交易進行了全面審查之後，我們將對該公司進行更詳細的審查。這包括評估其當前的市場狀況和表現。
Where Is Humacyte Standing Right Now?
Humacyte 現在站在哪裏？
- With a trading volume of 42,801,618, the price of HUMA is up by 66.66%, reaching $5.77.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 91 days from now.
- HUMA的交易量爲42,801,618美元，上漲了66.66％，達到5.77美元。
- 當前的RSI值表明該股可能接近超買。
- 下一份收益報告定於91天后發佈。
What Analysts Are Saying About Humacyte
分析師對Humacyte的看法
3 market experts have recently issued ratings for this stock, with a consensus target price of $21.666666666666668.
3位市場專家最近發佈了該股的評級，共識目標價爲21.6666666666668美元。
Unusual Options Activity Detected: Smart Money on the Move
檢測到不尋常的期權活動：智能貨幣在移動
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* Consistent in their evaluation, an analyst from D. Boral Capital keeps a Buy rating on Humacyte with a target price of $25. * An analyst from HC Wainwright & Co. has revised its rating downward to Buy, adjusting the price target to $15. * An analyst from D. Boral Capital persists with their Buy rating on Humacyte, maintaining a target price of $25.
Benzinga Edge的不尋常期權委員會在潛在的市場推動者發生之前就發現了它們。看看大筆資金對你最喜歡的股票持有哪些頭寸。點擊此處查看。* D.Boral Capital的一位分析師維持Humacyte的買入評級，目標價爲25美元。* HC Wainwright & Co. 的一位分析師已將其評級下調爲買入，將目標股價調整爲15美元。* D. Boral Capital的一位分析師堅持對Humacyte的買入評級，維持25美元的目標價。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Humacyte with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用Benzinga Pro了解Humacyte的最新期權交易，以獲取實時警報。
